Skip to content
Screener

Beta Bionics BBNX Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Insulet logo
InsuletPODD
$69.2M+21.2%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$44.05M-15.4%
Medtronic logo
MedtronicMDT
$2.06B+16.2%
AdaptHealth logo
AdaptHealthAHCO
$243.81M-0.2%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$102.68M+32.0%

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total debt$6.5M-2.6%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Market cap$737.83M+18.7%
Enterprise value$700.02M+18.0%
P/S6.2×-1.8×

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%
Debt / equity0.0×
Current ratio8.9×-5.8×

Where this comes from

Reported directly by Beta Bionics in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777
Line itemJune 30,2026December 31,2025
Total current liabilities26,01730,924
Operating lease liabilities, net of current portion4,9215,365
Deferred revenue, net of current portion3,4543,297
Other long-term liabilities1,6291,547
Total liabilities36,02141,133
Commitments and contingencies (Note 15)
Stockholders’ equity:
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025

Item 1. Financial Statements.

FAQ

What is Beta Bionics's other non-current liabilities?
Beta Bionics (BBNX) reported other non-current liabilities of $1.63M in Q2 2026.
How has Beta Bionics's other non-current liabilities changed year-over-year?
Beta Bionics's other non-current liabilities increased by 61.1% year-over-year, from $1.01M to $1.63M.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about Beta Bionics's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude